Sources state that Cinven is in exclusive discussions with Germany-based CeramTec priced at Eur1.5 billion.
Europe
Cost of insuring in emerging markets via CDS balloon
Investors' insurance cost via credit default swap increased. (Photo : Reuters )This is an image of an investor looking at a visual representation of stock market figures.
EU companies rewarded for 'bravery'
Europe's better performance gave companies who used 'brave' investments good results.
Emerging markets investments very risky - Investors
Investors said that emerging market assets are prone to inflation, making them a very risky place to invest in.
High yield investors' exodus returns European market to normal
High yield investors flee from the European junk bond market as funding costs increase. (Photo : reuters) This is an image of investors instenely watching the stock market.
Latest News
International Automotive Components announced its IPO filing valued at US$115 Million with BofA Merrill Lynch, JP Morgan and Deutsche Bank Securities as its underwriters.
Polkomtel was able to arrange for new financing in order to reduce overall debt burden. (Photo : Reuters)The image is the corporate logo of PKO Bank Polski SA.
BNP Paribas and Natixis is bidding to buyout Saur, the water and waste treatment utility. (Photo : Reuters)The image is the corporate logo of BNP Paribas SA.
Mercator shares owned by Pivovarna would be sold to Agrokor. (Photo : Reuters)The image is the corporate logo and byline of Mercator in Slovenian. Pivovarna Lasko, the largest beverage producer in Slovenia, had said that it would be selling off its shareholdings in Mercator, the largest food retailer in the country.
According to sources, Vodafone considers to improve its bid for Kabel Deutschland after the said deal to purchase the company at Eur81 per share.
Honeywell Industries, which purchased Intermec for US$600 million, has obtained approval from the European Commission.
Since February, top executives of Elan and Royalty Pharma have been vying to control over Elan. (Photo : Reuters )Irish drugmaker Elan will be giving back $1 billion to shareholders as a boost from the sale of its stake in multiple sclerosis treatment Tysabri to partner Biogen Idec.
Elan Pharmaceuticals has decided to sell itself after the many tendered offers it has received. (Photo : Reuters)The image is the logo of Elan Pharmaceuticals.
Vodafone is evaluation possible acquisition of Fastweb, Italy's third biggest retail broadband operator.
